GTS Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-83,700
Closed -$27M – 1357
2024
Q3
$27M Sell
83,700
-18,800
-18% -$6.15M 0.06% 199
2024
Q2
$32M Buy
102,500
+36,700
+56% +$10.8M 0.07% 163
2024
Q1
$18.7M Sell
65,800
-42,900
-39% -$12.6M 0.03% 285
2023
Q4
$31.3M Sell
108,700
-10,800
-9% -$2.94M 0.05% 215
2023
Q3
$32.1M Buy
+119,500
New +$29.8M 0.06% 193

Other funds holding AMGN

GTS Securities's AMGN Position: Q3 2026 in Review

GTS Securities increased its Amgen (AMGN) stake by 679% in Q3 2026, buying an estimated $13.5M and bringing the position to 38,873 shares worth $16.4M. The position accounts for 0.36% of the portfolio, ranked #53.

GTS Securities first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • GTS Securities held 38,873 shares of Amgen worth $16.4M as of Q3 2026.
  • GTS Securities bought 33,885 Amgen shares in Q3 2026, an estimated $13.5M.
  • Amgen made up 0.36% of GTS Securities's portfolio in Q3 2026, its #53 holding.
  • GTS Securities first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.